Stocksigma LogoStocksigma Logo

Indo Us Bio-Tech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 1,505 (-51.2% YoY | -54.4% QoQ) ■ EBITDA: -260 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -17.3 (Profit to Loss YoY | Profit

Indo Us Bio-Tech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

Indo Us Bio-Tech Ltd · Outcome · 30 Oct 2026, 9:42 pm

Indo Us Bio-Tech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 1,505 (-51.2% YoY | -54.4% QoQ) ■ EBITDA: -260 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -17.3 (Profit to Loss YoY | Profit to Loss QoQ) ■ PAT: -367 (Profit to Loss YoY | Profit to Loss QoQ) ■ EPS (INR): -1.83 (Profit to Loss YoY | Profit to Loss QoQ)

Original exchange filing (PDF)

More announcements from Indo Us Bio-Tech Ltd

All Indo Us Bio-Tech Ltd announcements